Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 3, 1999, Pages 733-740

  Murray, Jill ^a,b,c,d,e,f   Sonnenberg, Pamela ^a,b,c,d,e,f   Shearer, Stuart C ^a,b,c,d,e,f   Godfrey Faussett, Peter ^a,b,c,d,e,f  

^a National Centre for Occupational Health   (South Africa)

^b GOLD FIELDS LIMITED   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d Epidemiology Research Unit   (South Africa)

^e UNIVERSITY TEACHING HOSPITAL   (Zambia)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; AFRICA; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0033031177     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.3.9804147     Document Type: Article

References (32)

1. 1. De Cock, K., B. Soro, I. M. Coulibaly, and S. B. Lucas. 1992. Tuberculosis and HIV infection in sub-Saharan Africa. J.A.M.A. 268:1581-1587.
2. 2. Nunn, P. P., A. M. Elliot, and K. P. W. J. McAdam. 1994. Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax 49:511-518.
3. 3. Chaisson, R. E., G. F. Schecter, C. P. Theuer, G. W. Rutherford, D. F. Echenberg, and P. C. Hopewell. 1987. Tuberculosis in patients with the acquired immune deficiency syndrome: clinical features response to therapy and survival. Am. Rev. Respir. Dis. 136:570-574.
4. 4. Daley, C. L., P. M. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, D. Phi, W. R. Jacobs, and P. C. Hopewell. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N. Engl. J. Med. 326: 231-235.
5. 5. Harries, A. D., L. N. O. Mbewe, F. M. L. Salaniponi, D. S. Nyangulu, J. Veen, T. Ringdal, and P. Nunn. 1996. Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi. Lancet 347:807-809.
6. 6. World Health Organization. 1994. Framework for effective tuberculosis control. World Health Organization, Geneva.
7. 7. Nunn, P., R. Brindle, L. Carpenter, J. Odhiambo, K. Wasunna, R. Newnham, W. Githui, S. Gathua, M. Omwega, and K. McAdam. 1992. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (six-month) mortality. Am. Rev. Respir. Dis. 146:849-854.
8. 8. Perriens, J. H., R. L. Colebunders, C. Karahunga, J.-C. Willame, J. Jeugmans, M. Kaboto, Y. Mukadi, P. Pauwels, R. W. Ryder, J. Prignot, and P. Piot. 1991. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Am. Rev. Respir. Dis. 144:750-755.
9. 9. Ackah, A. N., D. Coulibaly, H. Digbeu, K. Diallo, K. M. Vetter, I. M. Coulibaly, A. Greenberg, and K. De Cock. 1995. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 345:607-610.
10. 10. Wilkinson, D., and D. A. J. Moore. 1996. HIV-related tuberculosis in South Africa - clinical features and outcome. S. Afr. Med. J. 86:64-67.
11. 11. Whalen, C., J. Okwera, J. Johnson, M. Vjecha, D. Hom, R. Wallis, R. Huebner, R. Mugerwa, and J. Ellner. 1996. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153:1977-1981.
12. 12. Perriens, J. H., E. Michael, B. M. Yiadiul, C. Brown, J. Prignot, F. Pouthier, F. Portaels, J.-C. Willame, J. K. Mandala, M. Kaboto, R. W. Ryder, G. Roscigno, and P. Piot. 1995. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N. Engl. J. Med. 332:779-784.
13. 13. Nolte, F. S., and B. Metchock. 1995. Mycobacterium. In P. R. Murray, F. J. Barron, M. A. Pfaller, F. C. Tenover, and R. I. Yolken, editors. Manual of Clinical Microbiology. American Society for Microbiology, Washington DC. 400-437.
14. 14. Siddiqui, S. B., J. E. Hawkins, and A. Laslo. 1985. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J. Clin. Microbiol. 22:919-923.
15. 15. Vestal, A. L. 1977. Procedures for the isolation and identification of mycobacteria. U.S. Department of Health, Education and Welfare, Centers for Disease Control, Atlanta. 97-115.
16. 16. Taylor, J. M. G., J. L. Fahey, R. Detels, and J. V. Giorgi. 1989. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 2:114-124.
17. 17. Centers for Disease Control and Prevention. 1992. Revised classification system for HIV infection. Morbid. Mortal. Weekly Rep. Vol. 41 (RR-17).
18. 18. SAS Institute Inc. 1988. SAS/STAT User's Guide. SAS Institute Inc., Cary, NC.
19. 19. South African National Department of Health. 1996. Report of the review of the tuberculosis control programme of South Africa.
20. 20. Snider, D. E. 1978. The relationship between tuberculosis and silicosis. Am. Rev. Respir. Dis. 118:455-460.
21. 21. Murray, J., D. Kielkowski, and P. Reid. 1996. Occupational disease trends in black South African gold miners. Am. J. Respir. Crit. Care Med. 153:706-710.
22. 22. Cowie, R. L., M. E. Langton, and M. R. Becklake. 1989. Pulmonary tuberculosis in South African gold miners. Am. Rev. Respir. Dis. 139: 1086-1089.
23. 23. Elliott, A. M., N. Luo, G. Tembo, B. Halwiindi, G. Steenbergen, L. Machiels, J. Pobee, P. Nunn, R. J. Hayes, and K. P. W. J. McAdam. 1990. Impact of HIV tuberculosis in Zambia: a cross sectional study. B.M.J. 301:412-415.
24. 24. Okwere, A., C. Whalen, F. Byekwaso, M. Vjecha, J. Johnson, R. Huebner, R. Mugerwa, and J. Ellner. 1994. Randomised trial of thiaceta-zone and rifampicin containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. Lancet 344:1323-1328.
25. 25. Grosset, J. H. 1992. Treatment of tuberculosis in HIV infection. Tubercle Lung Dis. 73:378-383.
26. 26. Small, P. M., G. F. Schecter, C. P. Theuer, G. W. Rutherford, D. F. Echenberg, and P. C. Hopewell. 1991. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 324:289-294.
27. 27. Cowie, R. L. 1990. The mycobacteriology of pulmonary tuberculosis in South African gold miners. Tubercle 71:39-42.
28. 28. Abouya, L., I. M. Coulibaly, D. Coulibaly, S. Kassim, A. Ackah, A. E. Greenberg, S. Z. Wiktor, and K. M. De Cock. 1995. Radiological manifestations of pulmonary tuberculosis in HIV-1-and HIV-2-infected patients in Abidjan, Cote d'Ivoire. Tubercle Lung Dis. 76:436-440.
29. + T-lymphocyte count. Tubercle Lung Dis. 76:518-521.
30. 30. Chaulet, P., F. Boulahbal, and J. Grosset. 1995. Surveillance of drug resistance for tuberculosis control: why and how? Tubercle Lung Dis. 76:487-492.
31. 31. Whalen, C., J. Okwera, J. Johnson, M. Vjecha, D. Hom, R. Wallis, R. Huebner, R. Mugerwa, and J. Ellner. 1996. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153:1977-1981.
32. 32. Kamanfu, G., N. Mlika-Cabanne, P.-M. Girard, S. Nimubona, B. Mpfizi, A. Cishako, P. Roux, J.-P. Coulaud, B. Larouze, P. Aubry, and J. F. Murray. 1993. Pulmonary complications of human Immunodeficiency virus infection in Bujumbura, Burundi. Am. Rev. Respir. Dis. 147:658-663.